Press Release
Global Insulin Delivery Devices Market is Estimated to Reach $22.8 Billion by 2024, Says Variant Market Research
 Published Date:  Sep 2017  Publish By: Variant Market Research

Global Insulin Delivery Devices Market Report, published by Variant Market Research, forecast that the global market is expected to reach $22.8 Billion by 2024 from $11.5 Billion in 2016, growing at a CAGR of 8.9% from 2016 to 2024. By geography, Asia Pacific and North America are expected to grow at a CAGR of 9.8% and 8.8%, respectively, during the forecast period.

"Insulin Delivery Devices Market (By Device Type: insulin pumps, insulin syringes, insulin pens and insulin jet injectors; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/medical-devices/insulin-delivery-devices-market

Some of the factors boosting the growth of the market include growing geriatric and obesity population, favoring reimbursement policies, rising awareness on drug delivery devices, and surge in demand for human insulin devices. Though, high costs and risks related with the misuse of drug delivery devices could hamper the growth. Moreover, market expansion and increasing number of R&D would provide several growth opportunities in forecast period.

Device type and geography are the two bifurcations considered in the global insulin delivery devices market. Device type is further categorized into insulin pumps, insulin syringes, insulin pens and insulin jet injectors. Among which, insulin syringes accounted the maximum share in 2016, and is expected to grow with the fastest CAGR during the forecast period.  Insulin pens held second largest share in 2016.

By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America held the major share in the market with 38.7% in 2016, followed by Europe with 26.1%. In terms of growth, Asia-Pacific is anticipated to attain fastest CAGR during the forecast period, driven by high diagnosis rate, changing consumer lifestyle, and increasing awareness among consumers and adoption of latest technologies.

Major players competing in the market include Medtronic plc, Eli Lilly and Company, Becton, Dickinson and Company, Tandem Diabetes Care, Inc., Ypsomed Holding AG, F. Hoffmann-La Roche, Ltd., Animas Corporation, Novo Nordisk A/S, B. Braun Melsungen AG, and Insulet Corporation, among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +91-953-444-8373
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.4.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Insulin Delivery Devices Market by Device Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Insulin Pumps
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Insulin Syringes
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Insulin Pens
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Insulin Jet Injectors
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
Chapter 5 Insulin Delivery Devices Market by Geography: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 North America
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
          5.2.3 US
                   5.2.3.1 Market Size and Forecast
          5.2.4 Canada
                   5.2.4.1 Market Size and Forecast
          5.2.5 Mexico
                   5.2.5.1 Market Size and Forecast
    5.3 Europe
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
          5.3.3 Germany
                   5.3.3.1 Market Size and Forecast
          5.3.4 France
                   5.3.4.1 Market Size and Forecast
          5.3.5 United Kingdom
                   5.3.5.1 Market Size and Forecast
          5.3.6 Italy
                   5.3.6.1 Market Size and Forecast
          5.3.7 Spain
                   5.3.7.1 Market Size and Forecast
          5.3.8 Others
                   5.3.8.1 Market Size and Forecast
    5.4 Asia-Pacific
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 China
                   5.4.3.1 Market Size and Forecast
          5.4.4 India
                   5.4.4.1 Market Size and Forecast
          5.4.5 Japan
                   5.4.5.1 Market Size and Forecast
          5.4.6 Others
                   5.4.6.1 Market Size and Forecast
    5.5 RoW
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Middle East
                   5.5.3.1 Market Size and Forecast
          5.5.4 South America
                   5.5.4.1 Market Size and Forecast
          5.5.5 Africa
                   5.5.5.1 Market Size and Forecast
Chapter 6 Company Profiles
    6.1 Medtronic plc
    6.2 Eli Lilly and Company
    6.3 Becton, Dickinson and Company
    6.4 Tandem Diabetes Care, Inc.
    6.5 Ypsomed Holding AG
    6.6 F. Hoffmann-La Roche, Ltd.
    6.7 Animas Corporation
    6.8 Novo Nordisk A/S
    6.9 B. Braun Melsungen AG
    6.10 Insulet Corporation
List of Figures
FIG. 1 MARKET SEGMENTATION: GLOBAL INSULIN DELIVERY DEVICES MARKET
FIG. 2 GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE AND FORECAST, BY DEVICE TYPE 2016 Vs 2024 (VALUE %)
FIG. 3 INSULIN PUMPS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 4 INSULIN SYRINGES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 5 INSULIN PENS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 6 INSULIN JET INJECTORS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 7 GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST BY GEOGRAPHY, 2016 Vs 2024 (REVENUE, CAGR %)
FIG. 8 NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 9 NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST BY COUNTRY, 2015 – 2024 ($ BILLION)
FIG. 10 U.S. INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 11 CANADA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 12 MEXICO INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 13 EUROPE INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 14 EUROPE INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST BY COUNTRY, 2015 – 2024 ($ BILLION)
FIG. 15 UK INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 16 GERMANY INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 17 FRANCE INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 18 ITALY INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 19 SPAIN INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 20 OTHER COUNTRIES IN EUROPE INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 21 ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 22 ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST BY COUNTRY, 2015 – 2024 ($ BILLION)
FIG. 23 CHINA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 24 JAPAN INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 25 INDIA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 26 OTHER COUNTRIES IN ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 27 REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 28 REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST BY COUNTRY, 2015 – 2024 ($ BILLION)
FIG. 29 SOUTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 30 MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 31 AFRICA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
List of Tables
TABLE 1 GLOBAL INSULIN DELIVERY DEVICES MARKET SNAPSHOT
TABLE 2 GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, BY REGION, 2015 – 2024 ($ BILLION)
TABLE 3 DRIVERS OF THE GLOBAL INSULIN DELIVERY DEVICES MARKET: IMPACT ANALYSIS
TABLE 4 RESTRAINTS OF THE GLOBAL INSULIN DELIVERY DEVICES MARKET: IMPACT ANALYSIS
TABLE 5 INSULIN PUMPS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 6 INSULIN SYRINGES MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 7 INSULIN PENS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 8 INSULIN JET INJECTORS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 9 NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, BY DEVICE TYPE, 2015 – 2024 ($ BILLION)
TABLE 10 EUROPE INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, BY DEVICE TYPE, 2015 – 2024 ($ BILLION)
TABLE 11 ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, BY DEVICE TYPE, 2015 – 2024 ($ BILLION)
TABLE 12 REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET SIZE AND FORECAST, BY DEVICE TYPE, 2015 – 2024 ($ BILLION)
TABLE 13 MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 14 ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 15 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 16 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT
TABLE 17 YPSOMED HOLDING AG: COMPANY SNAPSHOT
TABLE 18 F. HOFFMANN-LA ROCHE, LTD.: COMPANY SNAPSHOT
TABLE 19 ANIMAS CORPORATION: COMPANY SNAPSHOT
TABLE 20 NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 21 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 22 INSULET CORPORATION: COMPANY SNAPSHOT

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha